OMDA — Omada Health Income Statement
0.000.00%
- $827.80m
- $798.27m
- $169.80m
- 17
- 18
- 37
- 12
Annual income statement for Omada Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 89.2 | 123 | 170 |
Cost of Revenue | |||
Gross Profit | 42.8 | 70 | 103 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 162 | 190 | 213 |
Operating Profit | -72.3 | -67.5 | -43.7 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -72.5 | -67.5 | -47.1 |
Provision for Income Taxes | |||
Net Income After Taxes | -72.5 | -67.5 | -47.1 |
Net Income Before Extraordinary Items | |||
Net Income | -72.5 | -67.5 | -47.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -72.5 | -67.5 | -47.1 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -1.3 | -1.18 | -0.846 |